Revolution Medicines, Inc 10-Q for FY2022 Q3
Revolution Medicines, Inc. (RVMD)
10-Q
2022-11-07
For: 2022-09-30
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on November 7, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.36M
- up 204.8% from $1.1M a year earlier
- Net loss
- $73.33M
- compared with a net loss of $52.94M a year earlier
- Diluted EPS
- -$0.87
- compared with -$0.72 a year earlier